Objective
The European Lead Factory concept proposed by the EUC2LID Consortium relates to the discovery of novel small molecule candidates to serve as starting points for subsequent optimization to either drug candidates or high-quality pharmacological tools for the experimental validation of targets. The concept intends to bridge academic and applied research interests. The European Lead Factory will provide an industry-like small molecule discovery platform to public investigators. It builds on a unique, comprehensive, high-quality compound collection contributed by EFPIA Pparticipants, i.e. the Pharma Consortium Compound Collection totaling over about 300.000 compounds. Screening of these previously safeguarded corporate compound libraries against competitor’s targets and targets from public sources may result in otherwise inaccessible valuable lead structures that could ultimately result in the development of novel treatment options for patients. Academic Participantsa or other eligible bodies (and Contributing Third Parties) will be invited to submit proposals for screening of innovative targets and to suggest the design of new and diverse chemical libraries utilizing novel concepts and strategies. The latter will fuel the generation of a Public Compound Collection that will combine with the Pharma ConsortiumEFPIA Compound Collection to generate the Joint European Compound CollectionLibrary. These public sector contributions will not only provide a constant flow of innovation, but also generate opportunities for future partnerships amongst public Public Participants and private contributors EFPIA Participants on scientific and commercial grounds. EUC2LID’s overarching goal is value creation by screening the Joint European Compound Collection Library against in pPublic and private EFPIA Ttarget Programmes. Based on the successful delivery on its objectives during the IMI funding period, the generation of the high quality Public Compound Collection provides a tangible asset allowing the transition of the European Lead Factory into a novel sustainable business model, facilitating future public-private alliances based on pre-competitive, community-based efforts in early drug research.
Fields of science
Call for proposal
IMI-JU-05-2012
See other projects for this call
Coordinator
51373 Leverkusen
Germany
See on map
Participants (32)
2311 EZ Leiden
See on map
Participation ended
ML1 5UH Newhouse
See on map
5349 AB Oss
See on map
OX1 2JD Oxford
See on map
DD1 4HN Dundee
See on map
44227 Dortmund
See on map
6546BB Nijmegen
See on map
44227 Dortmund
See on map
69008 Lyon
See on map
9747 AT Groningen
See on map
NG1 1GF Nottingham
See on map
Participation ended
80333 Muenchen
See on map
3521 AL Utrecht
See on map
NG7 2RD Nottingham
See on map
Participation ended
1066 CX Amsterdam
See on map
45141 Essen
See on map
1081 HV Amsterdam
See on map
80539 Munchen
See on map
6525 XZ Nijmegen
See on map
2800 Kongens Lyngby
See on map
LS2 9JT Leeds
See on map
9712CP Groningen
See on map
2340 Beerse
See on map
64293 Darmstadt
See on map
151 85 Sodertaelje
See on map
65929 Frankfurt Am Main
See on map
1070 Bruxelles / Brussel
See on map
2500 Valby
See on map
1031 Budapest
See on map
ML1 5UH Newhouse
See on map
75008 Paris
See on map
2333 ZA Leiden
See on map